CoChat

11β-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Hypothalamus-Pituitary-Adrenal Axis, Metabolic Syndrome, and Inflammation

Cooper, Mark S., Stewart, Paul M. · 2009 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.

Abstract

CONTEXT: 11Beta-hydroxysteroid dehydrogenase (11beta-HSD) enzymes are now appreciated to be important regulators of hormone action at a tissue level. 11Beta-HSD1 is widely expressed and increases glucocorticoid action through its unique ability to convert inactive glucocorticoids (cortisone in man, 11-dehydrocorticosterone in rodents) to their active forms (cortisol and corticosterone, respectively). The enzyme has roles in the normal hypothalamus-pituitary-adrenal (HPA) axis, has been implicated in metabolic syndrome, and may modulate various aspects of the immune response. EVIDENCE ACQUISITION: A review of published, peer-reviewed medical literature (1990 to June 2009) on the physiology and pathophysiology of 11beta-HSD1 was performed with an emphasis on HPA axis consequences, the metabolic syndrome, and the inflammatory response. EVIDENCE SYNTHESIS: Studies of patients with genetic defects in 11beta-HSD1 action show abnormal HPA axis responses with hyperandrogenism being a major consequence. The mechanisms underlying these abnormalities have been explored in mouse models with targeted deletion of components of the 11beta-HSD1 system. A range of experimental studies emphasize the role of 11beta-HSD1 in the metabolic syndrome and the potential for treatment with chemical inhibitors. An emerging area is the role of 11beta-HSD1 in the inflammatory response. CONCLUSIONS: 11Beta-HSD1 activity is an important component of the HPA axis and contributes to the metabolic syndrome and the normal immune response. Ongoing clinical observations and the development of selective inhibitors will further clarify the role of 11beta-HSD1 in these areas.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2009-1412

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 101 references

Cited by

See all 184

Metadata

Authors
Cooper, M. S., & Stewart, P. M.
Affiliations
University of Birmingham (GB)
Corresponding author
Stewart, Paul M.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2009-12-01
Volume
94
Issue
12
Pages
4645-4654
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2046188044
Cited by
183
References
103
Citations by year
2026: 5 · 2025: 5 · 2024: 12 · 2023: 10 · 2022: 7 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 7 · 2017: 12 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 20 · 2012: 24
FWCI
2.62
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (acceptedVersion)
Funders
  • Wellcome Trust
  • National Institute for Health and Care Research (NF-SI-0508-10356)
  • Versus Arthritis
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
11β-hydroxysteroid dehydrogenase type 1, hypothalamic-pituitary-adrenal axis, metabolic syndrome, inflammation, glucocorticoid metabolism, cortisone, hyperandrogenism, 11β-HSD1 inhibitors, immune response
MeSH terms
Adipose Tissue, Animals, Humans, Hypothalamo-Hypophyseal System, Inflammation, Pituitary-Adrenal System, Metabolic Syndrome, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 11β-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Hypothalamus-Pituitary-Adrenal Axis, Metabolic Syndrome, and Inflammation. https://app.cochat.ai/papers/10.1210/jc.2009-1412
The paper
Cooper, M. S., & Stewart, P. M. (2009). 11β-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Hypothalamus-Pituitary-Adrenal Axis, Metabolic Syndrome, and Inflammation. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2009-1412

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.